Abstract Background Primary percutaneous coronary intervention (PCI) is the standard treatment in patients with ST-elevation myocardial infarction (STEMI). However, some patients still develop ST re-elevation during PCI, resulting in further…
Abstract Background To investigate clinical outcomes of percutaneous coronary intervention using a sirolimus-eluting stent with bioresorbable polymer, Ultimaster (BP-SES) compared with a permanent polymer everolimus-eluting stent, Xience (PP-EES) in patients…
Summer 2016 carried exciting news for bioresorbable scaffold (BRS) technology. On July 5, the US Food and Drug Administration (FDA) approved the Absorb GT1 (Abbott Vascular) poly(L-lactide) (PLLA)-based BRS for…
